ascopubs.org

Rethinking germline testing in localized prostate cancer: Prevalence of germline variants and association with Gleason score and NCCN risk grouping.

The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer.
ascopubs.org

The risk of death from prostate cancer in men with Gleason Score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy.

Impact of somatic SPOP (Speckle-Type POZ protein) mutation (mtSPOP) on response to systemic therapy and survival outcome in men with de novo metastatic castration-sensitive prostate cancer (d-mCSPC).
MedPage Today

Scott Eggener, MD, on Reasons to Rename Gleason Score 6 Prostate Cancer to Non-Cancer

Experts disagree on whether prostate cancer with a Gleason score of 6 (GS6) should be re-labeled as non-cancerous. Writing in a commentary in the Journal of Clinical Oncology, Scott Eggener, MD, and ...
Medscape

Importance and Determinants of Gleason Score Undergrading on Biopsy Sample of Prostate Cancer in a Population-based Study

1) OR: Odds Ratio derived from logistic regression considering as cases patients whose biopsy Gleason score was lower than the prostatectomy Gleason score and as controls everybody else, 2) ...